Pancreatic Islet Cell Tumor Clinical Trials

Find Pancreatic Islet Cell Tumor Clinical Trials Near You

SwissNET - a Prospective Registry of Patients With Neuroendocrine Tumours in Switzerland

Status: Terminated
Location: See all (55) locations...
Study Type: Observational
SUMMARY

Gastroentero-pancreatic neuroendocrine tumours (GEP-NETs) are regarded as a fairly rare disease. They are derived from the neuroendocrine system of the gastrointestinal tract and the pancreas and share common clinical features. So far, there is still uncertainty about the cell biology and mechanistic regulation of these tumours. Therefore targeted treatment is limited and management challenging. Treatment options include surgery, medical and ablative therapy, and more recently peptide-receptor radionuclide therapy. In order to better understand the characteristics of GEP-NETs and to evaluate treatment strategies, the SwissNET registry aims at the collection of data from patients presenting with a GEP-NET in Switzerland. Data will be entered prospectively and anonymized in a specifically designed database after the patient has given informed consent. All hospitals and general practitioners are invited to report on patients with a GEP-NET diagnosis and to participate to the registry. Data will be evaluated within regular time frames, focussing on types of GEP-NETs, treatment modalities and patient outcomes (e.g. mortality, hospitalisation rate), thereby contributing to the better understanding of these tumours.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Neuroendocrine tumor irrespective of primary tumor location

• Diagnosis in Switzerland

• Given informed consent

Locations
Other Locations
Switzerland
Kantonsspital Aarau
Aarau
Spitalnetz Bern Aarberg
Aarberg
Bezirksspital Affoltern
Affoltern Am Albis
Kantonsspital Uri, Altdorf
Altdorf
St. Claraspital
Basel
Universitätsspital Basel
Basel
Istituto oncologico della Svizzera italiana
Bellinzona
Div. of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital
Bern
Spital Tiefenau, Spitalnetz Bern
Bern
Zieglerspital Bern
Bern
Spitalzentrum Biel - Bienne
Biel
Kantonsspital Bruderholz
Bruderholz
Regionsspital Emmental
Burgdorf
Kantonsspital Chur
Chur
Private practise Dr. Mannhart
Churwalden
Hôpital du Jura
Delémont
Spital Dornach
Dornach
Regionalspital Einsiedeln
Einsiedeln
Hôpitaux Universitaires de Genève
Geneva
Spital Grabs
Grabs
See-Spital Horgen
Horgen
Spital Zimmerberg
Horgen
Fmi Spital Interlaken
Interlaken
Spital Lachen
Lachen
Spital Region Oberaargau
Langenthal
Kantonsspital Laufen
Laufen
Centre hospitalier universitaire vaudois, CHUV
Lausanne
Kantonsspital Liestal
Liestal
Hirslandenklinik St. Anna
Lucerne
Kantonsspital Luzern
Lucerne
Kantonsspital Sursee, Luzern
Lucerne
Kreisspital Männedorf
Männedorf
Kantonsspital Münsterlingen
Münsterlingen
Kantonsspital Olten
Olten
Gesundheitszentrum Fricktal
Rheinfelden
Kantonsspital St. Gallen
Sankt Gallen
Kantonsspital Obwalden
Sarnen
Spital Limmattal
Schlieren
Spital Schwyz
Schwyz
Privatpraxis Dr. H.J. Poths
Seuzach Dorf
Centre hospitalier du centre du Valais
Sion
Bürgerspital Solothurn
Solothurn
Kantonsspital Nidwalden
Stans
Thun Spital STS AG
Thun
Spital Uster
Uster
Regionalspital Visp
Visp
Kantonsspital Winterthur
Winterthur
Kantonsspital Wolhusen
Wolhusen
Spital Zollikerberg
Zollikerberg
Zuger Kantonsspital AG
Zug
Pathologie Medica Zürich
Zurich
Stadtspital Triemli
Zurich
Stadtspital Waid
Zurich
Universitätsspital Zürich
Zurich
STS AG Spital Zweisimmen
Zweisimmen
Time Frame
Start Date: 2008-01
Completion Date: 2025-08-31
Participants
Target number of participants: 1245
Treatments
1
Patients with a histologically confirmed diagnosis of a neuroendocrine tumor irrespective of primary tumor location
Related Therapeutic Areas
Sponsors
Collaborators: Spital STS AG, Spitalnetz Bern, University Hospital, Basel, Switzerland, Triemlispital Zurich, University Hospital, Geneva, Kantonsspital Liestal, Luzerner Kantonsspital, Spital Limmattal Schlieren, University of Lausanne Hospitals, Waid City Hospital, Zurich, Ente Ospedaliero Cantonale, Bellinzona, Cantonal Hospital of St. Gallen, Kantonsspital Graubünden, University Hospital, Zürich
Leads: Insel Gruppe AG, University Hospital Bern

This content was sourced from clinicaltrials.gov

Similar Clinical Trials